6877 — Top Eminent Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$300.93m
- HK$93.18m
- HK$102.25m
Annual cashflow statement for Top Eminent Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -57.9 | -31 | 14.6 | 12.6 | — |
| Depreciation | |||||
| Non-Cash Items | -0.928 | -1.8 | -12.6 | -8.86 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.94 | 13.4 | -0.582 | -23.9 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -39.3 | -16.8 | 1.82 | -19.9 | — |
| Capital Expenditures | -0.86 | -0.003 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.08 | 1.78 | 9.64 | 9.48 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.21 | 1.78 | 9.64 | 9.48 | — |
| Financing Cash Flow Items | -0.288 | -0.209 | -0.001 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10.1 | -2.12 | -0.001 | 0 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -52.6 | -22.7 | 10.6 | -17.2 | — |